|
RASAL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.610790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.016300E-04 |
| Normal-vs-Stage2 |
9.565200E-01 |
| Normal-vs-Stage3 |
5.758800E-01 |
| Normal-vs-Stage4 |
8.317700E-02 |
| Stage1-vs-Stage2 |
3.856100E-02 |
| Stage1-vs-Stage3 |
6.31500000000118E-05 |
| Stage1-vs-Stage4 |
1.98407999999484E-05 |
| Stage2-vs-Stage3 |
6.988200E-01 |
| Stage2-vs-Stage4 |
2.272000E-01 |
| Stage3-vs-Stage4 |
1.895390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.106000E-01 |
| Normal-vs-AfricanAmerican |
5.061200E-01 |
| Normal-vs-Asian |
1.851360E-01 |
| Caucasian-vs-AfricanAmerican |
9.845800E-01 |
| Caucasian-vs-Asian |
2.315400E-01 |
| AfricanAmerican-vs-Asian |
2.425800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.926600E-01 |
| Normal-vs-Female |
1.060030E-01 |
| Male-vs-Female |
4.769800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.305820E-01 |
| Normal-vs-Age(41-60Yrs) |
9.675100E-03 |
| Normal-vs-Age(61-80Yrs) |
7.286600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.856800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.888600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.862300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.706400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.603100E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.256100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.450800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.120500E-03 |
| Normal-vs-Grade 2 |
3.805500E-04 |
| Normal-vs-Grade 3 |
6.185000E-01 |
| Normal-vs-Grade 4 |
3.062300E-02 |
| Grade 1-vs-Grade 2 |
5.034200E-02 |
| Grade 1-vs-Grade 3 |
2.62829999997383E-06 |
| Grade 1-vs-Grade 4 |
3.54730000000636E-05 |
| Grade 2-vs-Grade 3 |
2.7338000000432E-06 |
| Grade 2-vs-Grade 4 |
2.27450000001017E-06 |
| Grade 3-vs-Grade 4 |
4.914500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.213810E-04 |
| Normal-vs-ccB subtype |
9.165800E-01 |
| ccA subtype-vs-ccB subtype |
7.60310000000874E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.402000E-01 |
| Normal-vs-N1 |
8.833800E-01 |
| N0-vs-N1 |
9.248800E-01 |
|
|
